''At 78 weeks, adjusted mean changes from baseline in daily insulin dose were significantly lower in the empagliflozin 10 and 25 mg groups than in the placebo group (-1.21 and -0.47 vs. ?5.45 IU/day; both p \ 0.01); respective baseline mean daily doses were 45.13, 48.43 and 47.84 IU/day [38].''
''At 52 weeks, adjusted mean changes from baseline in daily insulin dose were significantly lower in the empagliflozin 10 and 25 mg groups than in the placebo group (?1.3 and -1.1 vs. ?10.2 IU/day; both p \ 0.01); respective baseline mean daily doses were 90.4, 89.4 and 99.5 IU/day [38] .'' should read:
''At 78 weeks, adjusted mean changes from baseline in daily insulin dose were significantly lower in the empagliflozin 10 and 25 mg groups than in the placebo group (-1.21 and -0.47 vs. ?5.45 IU/day; both p \ 0.01); respective baseline mean daily doses were 45.13, 48.43 and 47.84 IU/day [38] .''
The online version of the original article can be found under doi:10.1007/s40265-014-0298-1.
